Psoriasis is an autoimmune disease that results from cross-talk between the epithelium and the immune system. Its prevalence ranges from 0.09–11.43%. Also, it has been linked to several comorbidities and other autoimmune diseases, such as inflammatory bowel disease, arthritis, cardiovascular disease, obesity, and diabetes mellitus (Qi et al. 2021).
Gamma-delta (γδ) T cells are a distinct subgroup of T lymphocytes (Ribot et al. 2021). Interleukin-17 (IL-17) is a pro-inflammatory cytokine that is linked to inflammatory and autoimmune diseases including psoriasis (Martin et al. 2013). In psoriasis, the immune response adapts and associates with pro-inflammatory subtypes of Th1 (T-helper), Th17, and Th22 cells. Th17 cells are widely recognized as the primary IL-17 producers. However, according to recent data, innate immune cells are responsible for producing a significant amount of the IL-17 released during inflammation (Keijsers et al. 2014).
Psoriasis does not occur naturally as a disease in mice. However, various xenotransplantation models and immunological reconstitution approaches have elucidated the psoriasis immunopathogenesis (Keijsers et al. 2014). In addition to IL-17-producing CD4+ T cells (Th17) in inflammatory diseases, γδ T-cells are the primary sources of IL-17 in mouse models (Akitsu and Iwakura 2018). The available evidence demonstrated that γδ T-cells that are abnormally activated can regulate the pathogenesis of psoriasis (Qi et al. 2021). However, the local immune response, cellular changes, and tissue-specific gene expression directly within the skin have not been fully elucidated (Qi et al. 2021). This lack of understanding hinders the development of more effective treatments for psoriasis. Additionally, human γδ T-cells display notable flexibility throughout their lifespan, with the capacity to generate various cytokines when exposed to specific triggers which contributes further to the difficulty in translating observations from murine models to humans (Qu et al. 2022).
While murine and human γδ T cells are similar in psoriasis pathogenesis, there are notable differences. Mice mainly use Vγ5Vδ1 TCR for psoriasis-like inflammation, while humans have more diverse TCR expressions like Vδ1, Vδ2, and Vδ3. The tissue distribution of γδ T cell subsets varies between mice and humans, possibly affecting their role in psoriatic inflammation. Human γδ T cells have diverse cytokine production profiles, including IL-17A and IFN-γ, unlike murine γδ T cells that are known for robust IL-17A production. Also, some γδ T-cell subsets in humans recognize stress-induced self-ligands on keratinocytes, contributing to psoriasis, while murine γδ T cells may respond to different antigens in the skin (Hu et al. 2023). Therefore, translating these findings to humans remains a challenge. Also, most studies on gamma-γδ T cells and IL-17 have been conducted using peripheral blood, cell cultures, or animal models (Moens et al. 2011; Sandrock et al. 2018; Agerholm et al. 2019). Nevertheless, the in-depth understanding of γδ T-cell function in the local immune response, cellular alterations, and gene expression in human psoriatic skin samples is not well understood.
Therefore, this study aimed to investigate the function of γδ-T cells in the pathophysiology of psoriasis and to gain new insights into its management by examining the relationship between IL-17 gene expression and γδ T-cell proliferation in human psoriatic tissue samples.